Fresenius Medical Care AG

39.97+0.0400+0.10%Vol 371.73K1Y Perf -7.01%
Aug 5th, 2021 16:00 DELAYED
BID35.10 ASK43.00
Open40.05 Previous Close39.93
Pre-Market- After-Market39.97
 - -  - -%
Target Price
41.80 
Analyst Rating
Strong Buy 1.33
Potential %
4.58 
Finscreener Ranking
★+     45.03
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.37
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     40.62
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★     40.69
Price Range Ratio 52W %
59.57 
Earnings Rating
Sell
Market Cap23.41B 
Earnings Date
30th Jul 2021
Alpha-0.01 Standard Deviation0.08
Beta1.29 

Today's Price Range

39.7940.09

52W Range

33.8444.13

5 Year PE Ratio Range

8.4028.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.65%
1 Month
-0.35%
3 Months
3.02%
6 Months
17.39%
1 Year
-7.01%
3 Years
-19.50%
5 Years
-13.30%
10 Years
19.79%

TickerPriceChg.Chg.%
FMS39.970.04000.10
AAPL147.060.11000.07
GOOG2 738.8018.23000.67
MSFT289.523.01001.05
XOM57.200.36000.63
WFC46.990.84001.82
JNJ173.690.33000.19
FB362.974.05001.13
GE103.020.11000.11
JPM153.151.91001.26
Financial StrengthValueIndustryS&P 500US Markets
0.70
1.10
0.47
1.13
5.50
Leverage Ratio 2.80
ProfitabilityValueIndustryS&P 500US Markets
30.10
11.80
21.90
11.90
7.16
RevenueValueIndustryS&P 500US Markets
16.43B
28.05
-1.00
0.24
DividendsValueIndustryS&P 500US Markets
2.14
0.82
9.26
11.09
Payout ratio30.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.510.46-9.80
Q01 20210.450.5113.33
Q04 20200.700.768.57
Q03 20200.660.717.58
Q02 20200.540.6622.22
Q01 20200.620.52-16.13
Q04 20190.680.7510.29
Q03 20190.590.6713.56
Earnings Per EndEstimateRevision %Trend
6/2021 QR0.51-3.77Negative
9/2021 QR0.56-3.45Negative
12/2021 FY2.15-5.70Negative
12/2022 FY2.50-3.47Negative
Next Report Date-
Estimated EPS Next Report0.51
Estimates Count1
EPS Growth Next 5 Years %2.60
Volume Overview
Volume371.73K
Shares Outstanding585.78M
Shares Float585.96M
Trades Count1.85K
Dollar Volume13.51M
Avg. Volume349.96K
Avg. Weekly Volume457.98K
Avg. Monthly Volume292.97K
Avg. Quarterly Volume256.07K

Fresenius Medical Care AG (NYSE: FMS) stock closed at 39.97 per share at the end of the most recent trading day (a 0.1% change compared to the prior day closing price) with a volume of 371.73K shares and market capitalization of 23.41B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 125364 people. Fresenius Medical Care AG CEO is Rice Powell.

The one-year performance of Fresenius Medical Care AG stock is -7.01%, while year-to-date (YTD) performance is -3.83%. FMS stock has a five-year performance of -13.3%. Its 52-week range is between 33.84 and 44.13, which gives FMS stock a 52-week price range ratio of 59.57%

Fresenius Medical Care AG currently has a PE ratio of 17.00, a price-to-book (PB) ratio of 1.62, a price-to-sale (PS) ratio of 1.37, a price to cashflow ratio of 5.00, a PEG ratio of 2.32, a ROA of 2.97%, a ROC of 4.90% and a ROE of 8.40%. The company’s profit margin is 7.16%, its EBITDA margin is 21.90%, and its revenue ttm is $16.43 Billion , which makes it $28.05 revenue per share.

Of the last four earnings reports from Fresenius Medical Care AG, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.51 for the next earnings report. Fresenius Medical Care AG’s next earnings report date is -.

The consensus rating of Wall Street analysts for Fresenius Medical Care AG is Strong Buy (1.33), with a target price of $41.8, which is +4.58% compared to the current price. The earnings rating for Fresenius Medical Care AG stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Fresenius Medical Care AG has a dividend yield of 2.14% with a dividend per share of $0.82 and a payout ratio of 30.00%.

Fresenius Medical Care AG has a Neutral technical analysis rating based on Technical Indicators (ADX : 10.57, ATR14 : 0.68, CCI20 : -61.46, Chaikin Money Flow : -0.12, MACD : -0.33, Money Flow Index : 37.87, ROC : 0.28, RSI : 46.30, STOCH (14,3) : 57.27, STOCH RSI : 0.62, UO : 45.59, Williams %R : -42.73), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Fresenius Medical Care AG in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
5 (83.33 %)
5 (83.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (16.67 %)
1 (16.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.33
Strong Buy
1.33
Strong Buy
1.33

Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

CEO: Rice Powell

Telephone: +49 61726082522

Address: Else-Kroener-Strasse 1, Bad Homburg 61352, , DE

Number of employees: 125 364

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

48%52%

Bearish Bullish

77%23%

News

Stocktwits